Gedea Biotech
Last verified 2026-05-02. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $6.2Mattributed |
|---|---|
| Latest round | grant, $2.7M, 2024-04-01attributed |
| Founded | 2015 |
| Headquarters | Lund, Sweden |
| Industry | biotech |
| Stage | unknown |
| Website | gedeabiotech.com |
Gedea Biotech develops pHyph, an antibiotic-free vaginal tablet that treats and prevents bacterial vaginosis by strengthening the vaginal microbiome. It is built for women suffering recurrent bacterial vaginosis and the clinicians treating them. Its trial data show 100 percent symptom-free patients at day 35 versus 54 to 77 percent for antibiotics, spun out of Lund University.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2024-04-01 | grant | $2.7M | undisclosed |
Detected tech stack
LiteSpeed, PHP 8.1.34, WordPress 7.0, Yoast SEO 27.5, Google Tag Manager, jQuery Migrate 3.4.1, PrestaShop, Zepto, WP Rocket, MailChimp, Python, MySQL
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $2.7M | attributed | eu-grant named as publisher. No document URL on file. |
| Total raised $6.2M | attributed | eu-grant named as publisher. No document URL on file. |
| Company existence | self-reported | gedeabiotech.com, read 2026-05-02 |
| Description | self-reported | gedeabiotech.com, read 2026-05-02 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.